Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $2.12 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.